https://newsletter.en.creamermedia.com
Africa|Health|Innovation|Installation|Manufacturing|Packaging|Training|Equipment|Manufacturing |Packaging|Operations
Africa|Health|Innovation|Installation|Manufacturing|Packaging|Training|Equipment|Manufacturing |Packaging|Operations
africa|health|innovation|installation|manufacturing|packaging-company|training|equipment|manufacturing-industry-term|packaging|operations

Pfizer/BioNTech strike South Africa COVID-19 manufacturing deal with Biovac

21st July 2021

By: Reuters

  

Font size: - +

Pfizer Inc and BioNTech SE on Wednesday said they had struck a deal for South Africa's Biovac Institute to process and distribute over 100 million doses a year of their Covid-19 vaccine for the African Union beginning in 2022.

Technical transfer, on-site development and equipment installation activities will begin immediately, they said. Biovac, a public-private partnership focused on vaccine production, will receive Covid-19 vaccine drug substance made in plants in Europe, and will begin so-called fill-finish operations, the last stage of drug manufacturing and packaging, in 2022.

Pfizer announced the partnership ahead of a speech by Chief Executive Albert Bourla at a World Trade Organization (WTO) Summit.

WTO members have been in talks for months on waiving drug firms' intellectual property (IP) rights for Covid-19 vaccines. Most developing countries support the waiver but several wealthy countries remain strongly opposed, saying it will deter research that allowed Covid-19 vaccines to be produced so quickly.

In his prepared remarks, Bourla made a plea for the group to maintain the current IP rules.

"Weakening IP rules will only discourage the type of unprecedented innovation which brought vaccines forward in record time and make it harder for companies to collaborate going forward," Bourla said.

Last month, the World Health Organization said it was setting up a hub, or training facility, in South Africa to give companies there the know-how and licenses to produce Covid-19 vaccines. Biovac was one of the initial participants in the hub.

Biovac has partnered with Pfizer since 2015 to manufacture and distribute its Prevenar 13 pneumonia vaccine.

Edited by Reuters

Article Enquiry

Email Article

Save Article

Feedback

To advertise email advertising@creamermedia.co.za or click here

Comments

Projects

Image of solar panels
Tournee Solar Park, South Africa
Updated 2 hours 18 minutes ago By: Sheila Barradas
Location map of the Bifrost project
Bifrost project, Denmark
Updated 2 hours 18 minutes ago By: Sheila Barradas

Showroom

Invincible Valves
Invincible Valves

Established in 1982, Invincible Valves is a medium-sized enterprise in Germiston, serving global and local markets.

VISIT SHOWROOM 
Iritron
Iritron

Iritron delivers advanced automation, control, and optimisation solutions to the Mining, Minerals & Metals, Consumer Package Goods and...

VISIT SHOWROOM 

Latest Multimedia

sponsored by

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







sq:0.176 0.27s - 167pq - 2rq
Subscribe Now